Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Not Yet Recruiting NCT07787039

Supporting Treatment for Opioids and Recovery Capital (STORC) - R61 Phase

Conditions: Opioid Use Disorder

Sex: Female
Ages: 18 Years – N/A
Healthy volunteers: No
Phase: NA
Enrollment: 10
Sponsor: Friends Research Institute, Inc.

Location: University of Pennsylvania Philadelphia Pennsylvania

Summary

We are studying whether training an identified support person and providing patient navigation (i.e. a peer recovery specialist assisting you with finding the right support) after delivery can increase "recovery capital"-the resources that help people with opioid use disorder (OUD) stay in treatment and recover. This study will build upon the research team's prior work in conducting research among pregnant and parenting women with OUD. This project will be directed by the research team at Friends Research Institute in close collaboration with their research and clinical partners at the University of Pennsylvania in Philadelphia, PA. A two-phase study is proposed with an initial 1-year developmental phase (R61) that will develop and pilot test STORC to include support person training. A second 4-year phase (R33) will test STORC in a parallel, two-arm, randomized controlled trial design at two study sites.

Eligibility Criteria

Inclusion Criteria: * must be biological females * must be currently within 6 weeks postpartum * must be able to read, write, and speak English at a 6th-grade level * must be diagnosed and receiving treatment for, or willing to receive treatment for opioid use disorder at the PROUD clinic * must identify a support person who also consents to participate. Patient participants must identify prospective support persons in order to complete consent Exclusion Criteria: * pregnancy * planned discharge to a long-term inpatient care facility (e.g., hospice) * hospitalization for a suicide attempt * major mental health disorder that requires treatment before OAT can be considered * stillbirth or neonatal death of the index pregnancy/infant, as determined from the obstetric record.

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07787039). StuddyBuddy aggregates publicly available trial information.